Skip to main content

Baxter CVE-2024-6796

CRITICAL
Improper Access Control (CWE-284)
2024-09-09 productsecurity@baxter.com
9.1
CVSS 3.1 · NVD
Share

Severity by source

NVD PRIMARY
9.1 CRITICAL
AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:N

Primary rating from NVD · only source for this CVE.

CVSS VectorNVD

Attack Vector
Network
Attack Complexity
Low
Privileges Required
None
User Interaction
None
Scope
Unchanged
Confidentiality
High
Integrity
High
Availability
None

Lifecycle Timeline

1
CVE Published
Sep 09, 2024 - 20:15 nvd
CRITICAL 9.1

DescriptionNVD

In Baxter Connex health portal released before 8/30/2024, an improper access control vulnerability has been found that could allow an unauthenticated attacker to gain unauthorized access to Connex portal's database and/or modify content.

AnalysisAI

In Baxter Connex health portal released before 8/30/2024, an improper access control vulnerability has been found that could allow an unauthenticated attacker to gain unauthorized access to Connex. Rated critical severity (CVSS 9.1), this vulnerability is remotely exploitable, no authentication required, low attack complexity. No vendor patch available.

Technical ContextAI

This vulnerability is classified under CWE-284. In Baxter Connex health portal released before 8/30/2024, an improper access control vulnerability has been found that could allow an unauthenticated attacker to gain unauthorized access to Connex portal's database and/or modify content. Affected products include: Baxter Connex Health Portal. Version information: before 8.

RemediationAI

No vendor patch is available at time of analysis. Monitor vendor advisories for updates. Apply vendor patches when available. Implement network segmentation and monitoring as interim mitigations.

More in Baxter

View all
CVE-2024-6795 CRITICAL
9.8 Sep 09

In Connex health portal released before8/30/2024, SQL injection vulnerabilities were found that could have allowed an un

CVE-2021-43935 CRITICAL
9.8 Dec 15

The impacted products, when configured to use SSO, are affected by an improper authentication vulnerability. Rated criti

CVE-2020-12047 CRITICAL
9.8 Jun 29

The Baxter Spectrum WBM (v17, v20D29, v20D30, v20D31, and v22D24), when used with a Baxter Spectrum v8.x (model 35700BAX

CVE-2020-12045 CRITICAL
9.8 Jun 29

The Baxter Spectrum WBM (v17, v20D29, v20D30, v20D31, and v22D24) when used in conjunction with a Baxter Spectrum v8.x (

CVE-2020-12043 CRITICAL
9.8 Jun 29

The Baxter Spectrum WBM (v17, v20D29, v20D30, v20D31, and v22D24) when configured for wireless networking the FTP servic

CVE-2020-12040 CRITICAL
9.8 Jun 29

Sigma Spectrum Infusion System v's6.x (model 35700BAX) and Baxter Spectrum Infusion System Version(s) 8.x (model 35700BA

CVE-2020-12016 CRITICAL
9.8 Jun 29

Baxter ExactaMix EM 2400 & EM 1200, Versions ExactaMix EM2400 Versions 1.10, 1.11, 1.13, 1.14, ExactaMix EM1200 Versions

CVE-2020-12041 CRITICAL
9.4 Jun 29

The Baxter Spectrum WBM (v17, v20D29, v20D30, v20D31, and v22D24) telnet Command-Line Interface, grants access to sensit

CVE-2020-12032 CRITICAL
9.1 Jun 29

Baxter ExactaMix EM 2400 Versions 1.10, 1.11 and ExactaMix EM1200 Versions 1.1, 1.2 systems store device data with sensi

CVE-2022-26393 HIGH
8.1 Sep 09

The Baxter Spectrum WBM is susceptible to format string attacks via application messaging. Rated high severity (CVSS 8.1

CVE-2020-12048 HIGH
7.5 Jun 29

Phoenix Hemodialysis Delivery System SW 3.36 and 3.40, The Phoenix Hemodialysis device does not support data-in-transit

CVE-2020-12037 HIGH
7.5 Jun 29

Baxter PrismaFlex all versions, PrisMax all versions prior to 3.x, The affected devices do not implement data-in-transit

Share

CVE-2024-6796 vulnerability details – vuln.today

This site uses cookies essential for authentication and security. No tracking or analytics cookies are used. Privacy Policy